Overview
What is Mclaughlin Research Institute For Biomedical Sciences?
The Mclaughlin Research Institute for Biomedical Sciences, located in Great Falls, Montana, is a dedicated nonprofit organization that strives to enhance human health through innovative genetic research and education. During fiscal year 2021, their scientists and staff delved into understanding the cellular and molecular mechanisms of neurodegenerative diseases, such as Alzheimer's, Frontotemporal Dementia, and Prion diseases, using genetic approaches in mouse models. They expanded their translational research program and collaborated with ten partners on 25 projects, contributing to $107,000 in grants and $692,000 in additional contracts. They also focused on Huntington's disease in partnership with investigators from Western Washington University and the Cure Huntington's Disease Foundation. Additionally, they made strides in investigator-led studies and future funding opportunities with the National Institutes of Health. Collaborations with pharmaceutical companies and the Believe in a Cure Foundation for orphan disease research in FoxG1 syndrome were also part of their efforts. The institute received funding, including a $405,000 annual grant for five years from the NIH, ultimately adding a new director and additional scientists. Their mission is to improve human health through genetic research and education.
Official website here: www.mclaughlinresearch.org
Is Mclaughlin Research Institute For Biomedical Sciences legitimate?
Mclaughlin Research Institute For Biomedical Sciences is a legitimate nonprofit organization registered as a 501(c)(3) entity. Mclaughlin Research Institute For Biomedical Sciences submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $296,114
Professional Fundraising Fees: $0
Other Salaries and Wages: $688,242
For more financial information, click here
Official website here: www.mclaughlinresearch.org
What is the mission statement of Mclaughlin Research Institute For Biomedical Sciences?
The Mclaughlin Research Institute for Biomedical Sciences aims to enhance human health through innovative genetic research and education. Their primary focus is on understanding the genetic control of normal development and susceptibility to neurological diseases using the mouse as a model. During fiscal year 2021, their scientists and staff continued to explore the cellular and molecular mechanisms of neurodegenerative disease processes, expanded their translational research program, and formed partnerships with various collaborators both nationally and internationally. The research primarily targeted the mechanisms behind protein misfolding in diseases such as frontotemporal dementia, Alzheimer's, and prion diseases, while exploring novel treatment approaches. The institute also collaborated with pharmaceutical companies for new treatment development and made strides in investigator-led studies and future funding opportunities with the National Institutes of Health. Additionally, they continued their efforts to understand Huntington's disease in collaboration with investigators from Western Washington University and the Cure Huntington's Disease Foundation.
Official website here: www.mclaughlinresearch.org
Who is the CEO of Mclaughlin Research Institute For Biomedical Sciences?
Renee Reijo Pera is the Principal Officer of Mclaughlin Research Institute For Biomedical Sciences.
Official website here: www.mclaughlinresearch.org
What is the revenue of Mclaughlin Research Institute For Biomedical Sciences?
Mclaughlin Research Institute For Biomedical Sciences's revenue in 2021 was $3,697,613.
Official website here: www.mclaughlinresearch.org
Who are the executives of Mclaughlin Research Institute For Biomedical Sciences and what are their salaries?
The average compensation at Mclaughlin Research Institute For Biomedical Sciences during 2021 was $42,798. There are 23 employees at Mclaughlin Research Institute For Biomedical Sciences.
Here are 14 key members and their salaries:
- Teresa Gunn (Associate Professor)
- Michael Kavanaugh Phd (Director)
- Maria Knapek (Fin And Res Sup Officer)
- Randy Gray (Chair) [Trustee/Director]
- Maxon Davis (Vice-President) [Trustee/Director]
- John Lane (Secretary) [Trustee/Director]
- Gene Thayer (Executive Board Member) [Trustee/Director]
- Gary Bjelland (Board Member) [Trustee/Director]
- David Cameron Phd (Board Member) [Trustee/Director]
- George A Carlson Phd (Board Member) [Trustee/Director]
- Bjarne Johnson (Board Member) [Trustee/Director]
- Erik Sletten (Board Member) [Trustee/Director]
- Dr Irving Weissman (Board Member) [Trustee/Director]
- Arlyne Reichert (Board Member) [Trustee/Director]
Official website here: www.mclaughlinresearch.org
Where can I find the form 990 for Mclaughlin Research Institute For Biomedical Sciences?
The Mclaughlin Research Institute For Biomedical Sciences’s most recent form 990 was submitted in 2021 and can be accessed here
Official website here: www.mclaughlinresearch.org
Learn more at the official website: www.mclaughlinresearch.org
Mission Statement of Mclaughlin Research Institute For Biomedical Sciences
The Mclaughlin Research Institute for Biomedical Sciences is committed to enhancing human health through innovative genetic research and education. Its primary mission lies in understanding the genetic control of normal development and susceptibility to neurological diseases, utilizing the mouse as a model. The institute's researchers focus on unraveling the cellular and molecular mechanisms behind neurodegenerative disease processes, expanding their translational research program, and supplementing treatment advancements.
During fiscal year 2021, the scientists and staff at the Mclaughlin Institute pursued this mission with dedication. They explored the mechanisms behind protein misfolding in diseases such as frontotemporal dementia, Alzheimer's, and prion diseases, and developed novel treatment approaches. Their work involved collaborations with up to ten collaborators and 25 projects among investigators, extending nationally to New York, Washington, Massachusetts, North Carolina, and Montana. These collaborations contributed to grants totaling $107,000 and additional contracts worth $692,000.
The institute also made significant strides in understanding Huntington's disease, collaborating with investigators from Western Washington University and the Cure Huntington's Disease Foundation. Moreover, they advanced investigator-led studies and explored future funding opportunities with the National Institutes of Health. In addition, they collaborated with several pharmaceutical companies to develop new treatments, and in collaboration with the Believe in a Cure Foundation, they focused on orphan disease research for FoxG1 syndrome.
The Mclaughlin Institute also continued its efforts on the NIH-funded grant (awarded in March 2018) worth $405,000 per year for five years, aimed at gaining insights into neurotransmitter electrophysiology in neurodegenerative diseases. This grant, totaling 1.75 million, included a funding match campaign of $980,000 aimed at the successful recruitment of a new director. This campaign was successfully completed in early 2021, resulting in the addition of an additional scientist and additional NIH-funded research at the institute.
Impact
This information is meant to be a general summary of Mclaughlin Research Institute For Biomedical Sciences. Please take the time to review official sources before making any decisions based upon the content provided here.
Saturday, July 20, 2024
Mclaughlin Research Institute For Biomedical Sciences has a significant impact on improving human health through innovative genetic research. In fiscal year 2021, the institute's scientists and staff focused on understanding the cellular and molecular mechanisms of neurodegenerative diseases, particularly the propagation of protein misfolding in diseases like frontotemporal dementia, Alzheimer's, and prion diseases. Their research efforts also extended to developing novel treatment approaches in collaboration with multiple partners across the nation.
The institute actively pursued funding opportunities, receiving grants and contracts totaling $107,000 and $692,000, respectively. They continued their critical work on Huntington's disease in partnership with other organizations and made progress in screening new treatments in collaboration with pharmaceutical companies. Additionally, they ventured into orphan disease research for FOXG1 syndrome in collaboration with the Believe in a Cure Foundation.
Notably, the institute successfully recruited a new director through a funding match campaign, welcoming an additional scientist and initiating new NIH-funded research in the field of neurodegenerative diseases. Overall, Mclaughlin Research Institute For Biomedical Sciences plays a vital role in advancing medical research and working towards improving treatments for neurological disorders.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2021.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
CONTRACT RESEARCH
Revenue
$694,299
Organization Details
Founding Year
1989
Phone
(406) 454-6015
Principal Officer
Renee Reijo Pera
Main Address
1520 23RD STREET SOUTH, GREAT FALLS, MT, 59405
Website
www.mclaughlinresearch.org
NTEE Category
Code: H90 - Medical research
If you are a representative of Mclaughlin Research Institute For Biomedical Sciences and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.